Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103).

Details

Language :

English

ISSN :

0732183X

Volume :

36

Issue :

25

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

131487996

Full Text :

https://doi.org/10.1200/JCO.2018.79.2028